嵌合受体毒素有希望成为治疗疾病的有效新武器。该毒素能杀死具有特异性表面受体的细胞,可用于治疗癌症患者和AIDS患者。美国国立癌症研究所的Pastan等构建的这种毒素是由生长因子、淋巴因子或激素的靶顺序与毒素基因的特异性片段融合而成。这种毒素的显著特性是缺乏细胞毒 Chimeric receptor toxins are promising as new and effective weapons to treat disease. The toxin can kill cells with specific surface receptors and can be used to treat cancer patients and AIDS patients. The toxin, constructed by Pastan et al. At the National Cancer Institute, is fused to a specific fragment of a toxin gene by the target sequence of growth factors, lymphokines, or hormones. A notable feature of this toxin is its lack of cytotoxicity